Donald E Adams - Net Worth and Insider Trading

Donald E Adams Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Donald E Adams owns 1 companies in total, including Provectus Biopharmaceuticals Inc (PVCT) .

Click here to see the complete history of Donald E Adams’s form 4 insider trades.

Insider Ownership Summary of Donald E Adams

Ticker Comapny Transaction Date Type of Owner
PVCT Provectus Biopharmaceuticals Inc 2006-06-08 10 percent owner

Donald E Adams Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Donald E Adams Ownership Network

Ownership Network List of Donald E Adams

No Data

Ownership Network Relation of Donald E Adams


Donald E Adams Owned Company Details

What does Provectus Biopharmaceuticals Inc do?

Who are the key executives at Provectus Biopharmaceuticals Inc?

Donald E Adams is the 10 percent owner of Provectus Biopharmaceuticals Inc. Other key executives at Provectus Biopharmaceuticals Inc include 10 percent owner Jeffrey Allen Morris , Chief Financial Officer Heather Raines , and See Remarks John R Glass .

Provectus Biopharmaceuticals Inc (PVCT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Provectus Biopharmaceuticals Inc (PVCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Provectus Biopharmaceuticals Inc (PVCT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Provectus Biopharmaceuticals Inc (PVCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Provectus Biopharmaceuticals Inc Insider Transactions

No Available Data

Donald E Adams Mailing Address

Above is the net worth, insider trading, and ownership report for Donald E Adams. You might contact Donald E Adams via mailing address: 370 Crestmont Drive, San Luis Obispo Ca 93401.

Discussions on Donald E Adams

No discussions yet.